The analysis by parity indicated that there were no statistically significant differences in adverse neonatal outcomes for nulliparous women although the numbers are much smaller than the Birthplace in England study.
As indicatedby a performance chart for one of the funds mentioned in the articles, AQR Risk Parity Fund (AQRIX), it is not easy to beat that benchmark even over a period of several years: